Bridgeway Capital Management’s C4 Therapeutics CCCC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$345K Hold
131,100
0.01% 900
2025
Q4
$250K Buy
131,100
+51,200
+64% +$121K 0.01% 976
2025
Q3
$177K Sell
79,900
-25,000
-24% -$60K ﹤0.01% 1035
2025
Q2
$150K Sell
104,900
-25,000
-19% -$36.4K ﹤0.01% 1015
2025
Q1
$208K Buy
+129,900
New +$387K 0.01% 920
2024
Q3
Sell
-49,000
Closed -$226K 1268
2024
Q2
$226K Hold
49,000
0.01% 1030
2024
Q1
$400K Sell
49,000
-75,000
-60% -$581K 0.01% 980
2023
Q4
$701K Sell
124,000
-25,000
-17% -$57K 0.02% 851
2023
Q3
$277K Buy
149,000
+49,000
+49% +$149K 0.01% 1028
2023
Q2
$275K Buy
+100,000
New +$321K 0.01% 1064

Other funds holding CCCC